View Older Stories
-
Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
-
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility
-
Elanco completes $120M Kansas facility expansion for mAb production
-
Elanco Animal Health (ELAN) Reiterated at Buy by Stifel as Rebate Activity Accelerates
-
FDA grants Elanco emergency authorization for screwworm wound spray
-
Elanco's CLiK(TM) Extra (Dicyclanil Topical Suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Liv
-
Elanco Animal Health (ELAN) Tops Q2 EPS by 7c; offers guidance
-
Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs
-
BofA keeps Elan as top pick in animal health sector ahead of 2Q26
-
Elanco study claims Credelio Quattro kills ticks faster than rivals
-
Piper Sandler Reiterates Overweight Rating on Elanco Animal Health (ELAN)
-
Elanco To Launch Elanco Ventures With $25 Million Multi-Year Commitment To Accelerate Innovation in Animal Health
-
Elanco Animal Health (ELAN) PT Raised to $32 at TD Cowen; Names Best Smidcap Idea
-
Elanco to launch $25M venture capital fund for animal health
-
Elanco receives USDA approval for combination dog vaccine
-
Elanco Animal Health (ELAN) call put ratio 2.2 calls to 1 put calls amid cattle screwworm headlines
-
Beef Supply Resilient, Screwworm or No, Elanco CEO Says - WSJ
-
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm
-
Elanco Animal Health (ELAN) July 31 and October 30 calls active amid cattle screwworm headlines
-
elanco offers treatment options for new world screwworm in U.S. livestock
-
Elanco launches Befrena for canine allergic dermatitis treatment
-
Elanco Animal Health (ELAN) PT Raised to $30 at Jefferies
-
Stifel Reiterates Buy Rating on Elanco Animal Health (ELAN)
-
Elanco Animal Health (ELAN) PT Raised to $32 at BofA Securities
-
Elanco Animal Health (ELAN) Tops Q1 EPS by 6c; offers guidance
-
Elanco Animal Health (ELAN) Reiterated at Buy by Stifel on Lowered Sales Estimates
-
Elanco Animal Health (ELAN): UBS Confident of 'Catalyst-Rich Story in 2026'
-
Elanco Animal Health (ELAN) Reiterated at Buy by Stifel On Continued Upside Bias
-
This company is set up well for 2026, says KeyBanc
-
'Elanco Animal Health (ELAN) set up well for beats and raises'; PT Raised to $29 at KeyBanc
-
Elanco Animal Health (ELAN) PT Raised to $30 at BofA Securities
-
Elanco Animal Health (ELAN) PT Raised to $30 at Leerink Partners
-
Elanco Animal Health (ELAN) Tops Q4 EPS by 2c ; Offers Guidance
-
Elanco Animal Health (ELAN) call put ratio 1 call to 1.6 puts
-
Piper Sandler Upgrades Elanco Animal Health (ELAN) to Overweight
-
Increasing unusual call option volume: EIX EWJ BRKR ELAN WSM BNC ENTG OGN
-
Elanco receives USDA approval for canine dermatitis treatment Befrena
-
Elanco Animal Health's (ELAN) Price Increases Estimate for 2026 is +3-4% - Stifel
-
Elanco receives first FDA conditional approval for screwworm treatment
-
KeyBanc sees a buying opportunity in this pet stock
-
Elanco Animal Health (ELAN) Can Drive +MSD% Revenue Growth - Stifel
-
KeyBanc on Elanco Animal Health (ELAN): 'We See Buying Opportunity with Stock Pullback'
-
Elanco Animal Health (ELAN) PT Raised to $26 at Leerink Partners
-
Elanco outlines growth targets and restructuring plan at investor day
-
Increasing unusual call option volume: ELAN JBS HLF NVRI
-
Elanco receives FDA emergency authorization for cat screwworm treatment
-
KeyBanc Starts Elanco Animal Health (ELAN) at Overweight
-
Elanco Animal Health (ELAN) Revenue Growth Estimates Raised at Stifel
-
Elanco Animal Health (ELAN) PT Raised to $25 at Leerink Partners
-
Elanco Animal Health (ELAN) Tops Q3 EPS by 6c, Beats on Revenue; Offers FY25 Guidance


